期刊
NATURE BIOTECHNOLOGY
卷 33, 期 11, 页码 1173-U102出版社
NATURE PORTFOLIO
DOI: 10.1038/nbt.3388
关键词
-
资金
- New York Stem Cell Foundation
- Maryland Stem Cell Research Fund (TEDCO)
- US National Institutes of Health (NIH) grant [P01GM099117]
- Howard Hughes Medical Institute (HHMI)
- MGH startup funds
- Gerald and Darlene Jordan Endowed Chair for Regenerative Medicine
- NIH [P01GM099117]
- Vranos Family Graduate Research Fellowship in Developmental & Regenerative Biology
The equivalence of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) remains controversial. Here we use genetically matched hESC and hiPSC lines to assess the contribution of cellular origin (hESC vs. hiPSC), the Sendai virus (SeV) reprogramming method and genetic background to transcriptional and DNA methylation patterns while controlling for cell line clonality and sex. We find that transcriptional and epigenetic variation originating from genetic background dominates over variation due to cellular origin or SeV infection. Moreover, the 49 differentially expressed genes we detect between genetically matched hESCs and hiPSCs neither predict functional outcome nor distinguish an independently derived, larger set of unmatched hESC and hiPSC lines. We conclude that hESCs and hiPSCs are molecularly and functionally equivalent and cannot be distinguished by a consistent gene expression signature. Our data further imply that genetic background variation is a major confounding factor for transcriptional and epigenetic comparisons of pluripotent cell lines, explaining some of the previously observed differences between genetically unmatched hESCs and hiPSCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据